# Crocker Capital

> Crocker Capital is a VC fund backing Biotechnology and Medical. See 2 investments, round sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: San Francisco, United States
- Total investments: 2
- Last investment: May 2013
- Lead investor: 0%
- Last updated: Aug 2026
- X (Twitter): https://www.twitter.com/crockercapital
- Website: http://www.crockercapital.com
- Facebook: https://www.facebook.com/crocker-capital-445631158962921

Crocker Capital is a private investment company. Its investment interests include select venture capital situations with particular interest in early stage companies. Crocker Capital will also, in conjunction with closely affiliated investors, undertake private equity investments, usually the purchase of majority control of a public or privateoperating company.

## Contacts

5 contacts available for Crocker Capital. Shizune tracks 1 team members at Crocker Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/crocker-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |
| Therapeutics | 1 | 50% |
| Medical Device | 1 | 50% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series B | 1 | 50% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Charles Crocker | CEO | 0 | — |

## Investments

| Company | Description | Round size | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Mercator MedSystems | Mercator MedSystems’ mission is to become a global leader in interventional, site-specific delivery of therapeutics that improve patient outcomes in vascular disease, oncology, and regenerative medicine.The 15th and 16th Centuries marked the beginning of the Age of Exploration, a time of bold action, vast territorial expansion and profoundintellectual discovery. Gerardus Mercator (1512-1594), a mathematician and cartographer, played a key role in these ventures. He was as important to navigation as Copernicus was to astronomy. He perfected a map projection that was the first to represent the spherical surface of the earth in two dimensions. The Mercator Projection effectively transformed navigation, making it possible for ships to deliver cargo safely to any port on the globe.Inspired by the spirit of our namesake, Mercator MedSystems has developed a medical technology that enables the safe and accurate delivery of therapies anywhere in the body, ranging from drugs for diseased blood vessels, to stem cells that regenerate ailing tissues and organs. We believe this breakthrough will allow the expansion of medical therapy and stimulate profound intellectual exploration into new treatments for disease.We invite you to explore our web site, our technology and products, and to follow our progress to a new world of therapeutic delivery. | $6.5M | Series B | May 30, 2013 |  |
| A&G Pharmaceutical | A&G Pharmaceutical is a theranostics company creating and developing monoclonal antibodies to cancer-specific targets as a basis for novel therapeutic and diagnostic products. The company is currently advancing a near-term opportunity to develop and commercialize a line of diagnostic test kits that will improve early detection, diagnosis, andtreatment of breast cancer based on GP88, a patented and proprietary growth factor discovered by A&G researchers. Concurrently, A&G's therapeutic division is pursuing development of anti-GP88 monoclonal antibody therapeutics for cancer. A&G's customized antibody service generates revenue to fund the drug development effort by accelerating the generation of novel, functional antibody therapeutics for leading pharmaceutical and biotechnology companies as well as federal laboratories. A&G has raised $3.5 million of equity capital and is located in Columbia, Md. | $2M | Series A | Sep 08, 2005 |  |

2 of 2 investments shown.

## Co-investors
- [Aphelion Capital](https://shizune.co/investors/profile/aphelion-capital) — VC Fund, 1 deal together
- [Maryland Venture Fund](https://shizune.co/investors/profile/maryland-venture-fund) — VC Fund, 1 deal together
- New England Partners — VC Fund, 1 deal together
- [Volcano Capital](https://shizune.co/investors/profile/volcano-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Crocker Capital invest in?

Crocker Capital invests primarily in Biotechnology, Medical and Health Care startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Crocker Capital?

Public channels for Crocker Capital include X (Twitter), the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Crocker Capital?

The team at Crocker Capital includes Charles Crocker (CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co